Report Detail
Global (United States, European Union and China) Anti - Neoplastic Agents Market Research Report 2019-2025
- RnM3702572 |
- 27 August, 2019 |
- Global |
- 125 Pages |
- QYResearch |
- Pharma & Healthcare
Cancer Treatment Drugs are used to treat malignancies, or cancerous growths. Depending on the technology it cans classification into Chemotherapy, Targeted Therapy, Immunotherapy (Biologic Therapy), Hormonal Therapy and Others.
In 2019, the market size of Anti - Neoplastic Agents is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Anti - Neoplastic Agents.
This report studies the global market size of Anti - Neoplastic Agents, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Anti - Neoplastic Agents sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Roche
Novartis
Celgene
Bristol-Myers Squibb
Amgen
Johnson & Johnson
Pfizer
Takeda
Eli Lilly
AstraZeneca
Astellas
Merck & Co.
Sanofi
Bayer
Biogen Idec
Eisai
Teva
Otsuka
Merck KGaA
Ipsen
AbbVie
Gilead Sciences
Market Segment by Product Type
Chemotherapy
Targeted Therapy
Immunotherapy
Hormonal Therapy (Biologic Therapy)
Others
Market Segment by Application
Blood Cancer
Breast Cancer
Gastrointestinal Cancer
Prostate Cancer
Respiratory/Lung Cancer
Other Cancers
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Anti - Neoplastic Agents status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Anti - Neoplastic Agents manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Anti - Neoplastic Agents are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Major Manufacturers Covered in This Report
- 1.3 Market Segment by Type
- 1.3.1 Global Anti - Neoplastic Agents Market Size Growth Rate by Type (2019-2025)
- 1.3.2 Chemotherapy
- 1.3.3 Targeted Therapy
- 1.3.4 Immunotherapy
- 1.3.5 Hormonal Therapy (Biologic Therapy)
- 1.3.6 Others
- 1.4 Market Segment by Application
- 1.4.1 Global Anti - Neoplastic Agents Market Share by Application (2019-2025)
- 1.4.2 Blood Cancer
- 1.4.3 Breast Cancer
- 1.4.4 Gastrointestinal Cancer
- 1.4.5 Prostate Cancer
- 1.4.6 Respiratory/Lung Cancer
- 1.4.7 Other Cancers
- 1.5 Study Objectives
- 1.6 Years Considered
2 Global Growth Trends
- 2.1 Global Anti - Neoplastic Agents Market Size
- 2.1.1 Global Anti - Neoplastic Agents Revenue 2014-2025
- 2.1.2 Global Anti - Neoplastic Agents Sales 2014-2025
- 2.2 Anti - Neoplastic Agents Growth Rate by Regions
- 2.2.1 Global Anti - Neoplastic Agents Sales by Regions 2014-2019
- 2.2.2 Global Anti - Neoplastic Agents Revenue by Regions 2014-2019
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
3 Market Share by Manufacturers
- 3.1 Anti - Neoplastic Agents Sales by Manufacturers
- 3.1.1 Anti - Neoplastic Agents Sales by Manufacturers 2014-2019
- 3.1.2 Anti - Neoplastic Agents Sales Market Share by Manufacturers 2014-2019
- 3.2 Revenue by Manufacturers
- 3.2.1 Anti - Neoplastic Agents Revenue by Manufacturers (2014-2019)
- 3.2.2 Anti - Neoplastic Agents Revenue Share by Manufacturers (2014-2019)
- 3.2.3 Global Anti - Neoplastic Agents Market Concentration Ratio (CR5 and HHI)
- 3.3 Anti - Neoplastic Agents Price by Manufacturers
- 3.4 Key Manufacturers Anti - Neoplastic Agents Plants/Factories Distribution and Area Served
- 3.5 Date of Key Manufacturers Enter into Anti - Neoplastic Agents Market
- 3.6 Key Manufacturers Anti - Neoplastic Agents Product Offered
- 3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
- 4.1 Sales and Revenue for Each Type
- 4.1.1 Chemotherapy Sales and Revenue (2014-2019)
- 4.1.2 Targeted Therapy Sales and Revenue (2014-2019)
- 4.1.3 Immunotherapy Sales and Revenue (2014-2019)
- 4.1.4 Hormonal Therapy (Biologic Therapy) Sales and Revenue (2014-2019)
- 4.1.5 Others Sales and Revenue (2014-2019)
- 4.2 Global Anti - Neoplastic Agents Sales Market Share by Type
- 4.3 Global Anti - Neoplastic Agents Revenue Market Share by Type
- 4.4 Anti - Neoplastic Agents Price by Type
5 Market Size by Application
- 5.1 Overview
- 5.2 Global Anti - Neoplastic Agents Sales by Application
6 United States
- 6.1 United States Anti - Neoplastic Agents Breakdown Data by Company
- 6.2 United States Anti - Neoplastic Agents Breakdown Data by Type
- 6.3 United States Anti - Neoplastic Agents Breakdown Data by Application
7 European Union
- 7.1 European Union Anti - Neoplastic Agents Breakdown Data by Company
- 7.2 European Union Anti - Neoplastic Agents Breakdown Data by Type
- 7.3 European Union Anti - Neoplastic Agents Breakdown Data by Application
8 China
- 8.1 China Anti - Neoplastic Agents Breakdown Data by Company
- 8.2 China Anti - Neoplastic Agents Breakdown Data by Type
- 8.3 China Anti - Neoplastic Agents Breakdown Data by Application
9 Rest of World
- 9.1 Rest of World Anti - Neoplastic Agents Breakdown Data by Company
- 9.2 Rest of World Anti - Neoplastic Agents Breakdown Data by Type
- 9.3 Rest of World Anti - Neoplastic Agents Breakdown Data by Application
- 9.4 Rest of World Anti - Neoplastic Agents Breakdown Data by Countries
- 9.4.1 Rest of World Anti - Neoplastic Agents Sales by Countries
- 9.4.2 Rest of World Anti - Neoplastic Agents Revenue by Countries
- 9.4.3 Japan
- 9.4.4 Korea
- 9.4.5 India
- 9.4.6 Southeast Asia
10 Company Profiles
- 10.1 Roche
- 10.1.1 Roche Company Details
- 10.1.2 Company Description and Business Overview
- 10.1.3 Sales, Revenue and Market Share of Anti - Neoplastic Agents
- 10.1.4 Anti - Neoplastic Agents Product Introduction
- 10.1.5 Roche Recent Development
- 10.2 Novartis
- 10.2.1 Novartis Company Details
- 10.2.2 Company Description and Business Overview
- 10.2.3 Sales, Revenue and Market Share of Anti - Neoplastic Agents
- 10.2.4 Anti - Neoplastic Agents Product Introduction
- 10.2.5 Novartis Recent Development
- 10.3 Celgene
- 10.3.1 Celgene Company Details
- 10.3.2 Company Description and Business Overview
- 10.3.3 Sales, Revenue and Market Share of Anti - Neoplastic Agents
- 10.3.4 Anti - Neoplastic Agents Product Introduction
- 10.3.5 Celgene Recent Development
- 10.4 Bristol-Myers Squibb
- 10.4.1 Bristol-Myers Squibb Company Details
- 10.4.2 Company Description and Business Overview
- 10.4.3 Sales, Revenue and Market Share of Anti - Neoplastic Agents
- 10.4.4 Anti - Neoplastic Agents Product Introduction
- 10.4.5 Bristol-Myers Squibb Recent Development
- 10.5 Amgen
- 10.5.1 Amgen Company Details
- 10.5.2 Company Description and Business Overview
- 10.5.3 Sales, Revenue and Market Share of Anti - Neoplastic Agents
- 10.5.4 Anti - Neoplastic Agents Product Introduction
- 10.5.5 Amgen Recent Development
- 10.6 Johnson & Johnson
- 10.6.1 Johnson & Johnson Company Details
- 10.6.2 Company Description and Business Overview
- 10.6.3 Sales, Revenue and Market Share of Anti - Neoplastic Agents
- 10.6.4 Anti - Neoplastic Agents Product Introduction
- 10.6.5 Johnson & Johnson Recent Development
- 10.7 Pfizer
- 10.7.1 Pfizer Company Details
- 10.7.2 Company Description and Business Overview
- 10.7.3 Sales, Revenue and Market Share of Anti - Neoplastic Agents
- 10.7.4 Anti - Neoplastic Agents Product Introduction
- 10.7.5 Pfizer Recent Development
- 10.8 Takeda
- 10.8.1 Takeda Company Details
- 10.8.2 Company Description and Business Overview
- 10.8.3 Sales, Revenue and Market Share of Anti - Neoplastic Agents
- 10.8.4 Anti - Neoplastic Agents Product Introduction
- 10.8.5 Takeda Recent Development
- 10.9 Eli Lilly
- 10.9.1 Eli Lilly Company Details
- 10.9.2 Company Description and Business Overview
- 10.9.3 Sales, Revenue and Market Share of Anti - Neoplastic Agents
- 10.9.4 Anti - Neoplastic Agents Product Introduction
- 10.9.5 Eli Lilly Recent Development
- 10.10 AstraZeneca
- 10.10.1 AstraZeneca Company Details
- 10.10.2 Company Description and Business Overview
- 10.10.3 Sales, Revenue and Market Share of Anti - Neoplastic Agents
- 10.10.4 Anti - Neoplastic Agents Product Introduction
- 10.10.5 AstraZeneca Recent Development
- 10.11 Astellas
- 10.12 Merck & Co.
- 10.13 Sanofi
- 10.14 Bayer
- 10.15 Biogen Idec
- 10.16 Eisai
- 10.17 Teva
- 10.18 Otsuka
- 10.19 Merck KGaA
- 10.20 Ipsen
- 10.21 AbbVie
- 10.22 Gilead Sciences
11 Value Chain and Sales Channels Analysis
- 11.1 Value Chain Analysis
- 11.2 Sales Channels Analysis
- 11.2.1 Anti - Neoplastic Agents Sales Channels
- 11.2.2 Anti - Neoplastic Agents Distributors
- 11.3 Anti - Neoplastic Agents Customers
12 Market Forecast
- 12.1 Global Anti - Neoplastic Agents Sales and Revenue Forecast 2019-2025
- 12.2 Global Anti - Neoplastic Agents Sales Forecast by Type
- 12.3 Global Anti - Neoplastic Agents Sales Forecast by Application
- 12.4 Anti - Neoplastic Agents Forecast by Regions
- 12.4.1 Global Anti - Neoplastic Agents Sales Forecast by Regions 2019-2025
- 12.4.2 Global Anti - Neoplastic Agents Revenue Forecast by Regions 2019-2025
- 12.5 United States Market Forecast
- 12.6 European Union Market Forecast
- 12.7 China Market Forecast
- 12.8 Rest of World
- 12.8.1 Japan
- 12.8.2 Korea
- 12.8.3 India
13 Research Findings and Conclusion
14 Appendix
- 14.1 Research Methodology
- 14.1.1 Methodology/Research Approach
- 14.1.1.1 Research Programs/Design
- 14.1.1.2 Market Size Estimation
- 14.1.1.3 Market Breakdown and Data Triangulation
- 14.1.2 Data Source
- 14.1.2.1 Secondary Sources
- 14.1.2.2 Primary Sources
- 14.1.1 Methodology/Research Approach
- 14.2 Author Details
Summary:
Get latest Market Research Reports on Anti - Neoplastic Agents. Industry analysis & Market Report on Anti - Neoplastic Agents is a syndicated market report, published as Global (United States, European Union and China) Anti - Neoplastic Agents Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Anti - Neoplastic Agents market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
